By Christy Santhosh and Padmanabhan Ananthan Sept 21 (Reuters) – The US FDA's staff reviewers did not raise major concerns about the accuracy and safety of Grail's blood test designed to detect more
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Jody Godoy and Deborah Mary Sophia Sept 21 (Reuters) - Paramount Skydance emerged victorious…
* Norway wants EU to drop its opposition to new Arctic oil and gas drilling…
VIDEO SHOWS: ARCHIVE VIDEO OF FIFA PRESIDENT GIANNI INFANTINO / ARCHIVE VIDEO OF FIFA HEADQUARTERS COMPLETE…
HOUSTON, Sept 21 (Reuters) - Texas Governor Greg Abbott said on Monday he had halted…
By Rodrigo Campos NEW YORK, Sept 21 (Reuters) - Adoption of artificial intelligence could leave…
By Munsif Vengattil BENGALURU, Sept 21 (Reuters) - Google said on Monday it has agreed…